Gelone Steven P.
Insider CIK 1693064 · NBRV President and COO, Director · NBRV Chief Development Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2023-01-29 | 2023-01-31 | 140 | $1.50 | $210 | 14,283 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2023-01-06 | 2023-01-10 | 5 | $1.30 | $7 | 14,423 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-12-31 | 2023-01-04 | 3 | $1.89 | $6 | 14,428 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-12-06 | 2022-12-08 | 4 | $2.02 | $8 | 14,431 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-11-30 | 2022-12-02 | 3 | $2.25 | $7 | 14,435 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-11-06 | 2022-11-08 | 4 | $2.24 | $9 | 14,438 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-10-31 | 2022-11-01 | 3 | $2.54 | $8 | 14,442 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-10-06 | 2022-10-11 | 4 | $2.72 | $11 | 14,445 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-09-30 | 2022-10-04 | 3 | $2.08 | $6 | 14,449 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-09-06 | 2022-09-07 | 89 | $0.16 | $14 | 361,311 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-08-31 | 2022-09-01 | 61 | $0.16 | $10 | 361,400 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2022-08-11 | 2022-08-15 | 46,700 | — | $0 | 0 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2022-08-11 | 2022-08-15 | 93,400 | — | $0 | 0 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2022-08-11 | 2022-08-15 | 93,400 | — | $0 | 93,400 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2022-08-11 | 2022-08-15 | 46,700 | — | $0 | 46,700 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-08-06 | 2022-08-08 | 89 | $0.18 | $16 | 361,461 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-07-31 | 2022-08-03 | 61 | $0.18 | $11 | 361,550 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-07-06 | 2022-07-07 | 89 | $0.18 | $16 | 361,611 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-06-30 | 2022-07-01 | 61 | $0.18 | $11 | 361,700 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-06-06 | 2022-06-07 | 89 | $0.20 | $18 | 361,761 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-05-31 | 2022-06-02 | 61 | $0.21 | $13 | 361,850 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-05-06 | 2022-05-09 | 89 | $0.26 | $23 | 361,911 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-04-30 | 2022-05-03 | 61 | $0.31 | $19 | 362,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-04-06 | 2022-04-08 | 89 | $0.41 | $36 | 362,061 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-03-31 | 2022-04-04 | 61 | $0.42 | $26 | 362,150 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-03-06 | 2022-03-08 | 89 | $0.43 | $38 | 362,211 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-02-28 | 2022-03-02 | 61 | $0.45 | $27 | 362,300 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-02-06 | 2022-02-08 | 106 | $0.48 | $51 | 362,361 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-01-31 | 2022-02-01 | 73 | $0.48 | $35 | 362,467 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-01-29 | 2022-02-01 | 3,483 | $0.45 | $1.6K | 362,540 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2022-01-28 | 2022-02-01 | 93,400 | — | $0 | 93,400 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2022-01-28 | 2022-02-01 | 46,700 | — | $0 | 46,700 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2022-01-06 | 2022-01-10 | 110 | $0.58 | $64 | 366,023 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-12-31 | 2022-01-04 | 63 | $0.60 | $38 | 366,133 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-12-06 | 2021-12-08 | 92 | $0.72 | $66 | 366,196 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-11-30 | 2021-12-02 | 63 | $0.78 | $49 | 366,288 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-11-06 | 2021-11-09 | 92 | $1.33 | $122 | 366,351 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-10-31 | 2021-11-01 | 63 | $1.15 | $72 | 366,443 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-10-06 | 2021-10-08 | 92 | $1.08 | $99 | 366,506 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-09-30 | 2021-10-04 | 63 | $1.19 | $75 | 366,598 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-09-06 | 2021-09-08 | 93 | $1.11 | $103 | 366,661 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-08-31 | 2021-09-02 | 63 | $1.06 | $67 | 366,754 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-08-06 | 2021-08-10 | 92 | $1.17 | $108 | 366,817 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-07-31 | 2021-08-03 | 63 | $1.10 | $69 | 366,909 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-07-06 | 2021-07-08 | 92 | $1.27 | $117 | 366,972 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-06-30 | 2021-07-02 | 63 | $1.35 | $85 | 367,064 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-06-06 | 2021-06-08 | 92 | $1.34 | $123 | 367,127 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-05-31 | 2021-06-02 | 63 | $1.38 | $87 | 367,219 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-05-06 | 2021-05-10 | 92 | $1.49 | $137 | 367,282 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-04-30 | 2021-05-04 | 63 | $1.78 | $112 | 367,374 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2021-04-28 | 2021-04-30 | 290,697 | — | $0 | 367,437 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-04-06 | 2021-04-08 | 92 | $1.73 | $159 | 76,740 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-03-31 | 2021-04-02 | 63 | $1.66 | $105 | 78,028 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-03-06 | 2021-04-08 | 92 | $1.79 | $165 | 76,832 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-02-28 | 2021-03-02 | 63 | $2.39 | $151 | 78,091 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-02-06 | 2021-04-08 | 1,104 | $2.90 | $3.2K | 76,924 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-01-31 | 2021-02-02 | 75 | $2.62 | $197 | 78,154 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2021-01-29 | 2021-02-02 | 42,500 | — | $0 | 78,229 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-12-31 | 2021-01-05 | 63 | $2.42 | $152 | 35,729 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-11-30 | 2020-12-01 | 628 | $0.43 | $270 | 357,926 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-10-31 | 2020-11-02 | 628 | $0.50 | $314 | 358,554 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-09-30 | 2020-10-01 | 628 | $0.53 | $333 | 359,182 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-08-31 | 2020-09-02 | 628 | $0.62 | $389 | 359,810 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-08-20 | 2020-08-21 | 3,204 | $0.65 | $2.1K | 364,995 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-08-20 | 2020-08-21 | 4,557 | $0.65 | $3.0K | 360,438 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2020-08-19 | 2020-08-21 | 11,250 | — | $0 | 0 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2020-08-19 | 2020-08-21 | 16,000 | — | $0 | 0 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise | 2020-08-19 | 2020-08-21 | 16,000 | — | $0 | 368,199 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise | 2020-08-19 | 2020-08-21 | 11,250 | — | $0 | 352,199 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-07-31 | 2020-08-04 | 628 | $0.76 | $477 | 340,949 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-06-30 | 2020-07-02 | 628 | $0.67 | $421 | 341,577 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-05-31 | 2020-06-03 | 628 | $1.14 | $716 | 342,205 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-04-30 | 2020-05-04 | 606 | $0.55 | $333 | 336,646 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-03-31 | 2020-04-02 | 606 | $0.58 | $351 | 337,252 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-02-28 | 2020-03-03 | 606 | $1.35 | $818 | 337,858 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2020-02-06 | 2020-02-10 | 310,000 | — | $0 | 310,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2020-02-06 | 2020-02-10 | 155,000 | — | $0 | 326,919 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-01-31 | 2020-02-04 | 8,651 | $1.35 | $11.7K | 171,919 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2019-08-21 | 2019-08-21 | 4,816 | $2.08 | $10.0K | 47,570 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2019-08-21 | 2019-08-21 | 3,390 | $2.08 | $7.1K | 52,386 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2019-08-21 | 2019-08-26 | 3,390 | $2.08 | $7.1K | 52,386 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2019-08-21 | 2019-08-26 | 4,816 | $2.08 | $10.0K | 47,570 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2019-08-19 | 2019-08-21 | 16,000 | — | $0 | 16,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2019-08-19 | 2019-08-21 | 11,250 | — | $0 | 11,250 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise | 2019-08-19 | 2019-08-21 | 11,250 | — | $0 | 33,776 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise | 2019-08-19 | 2019-08-21 | 16,000 | — | $0 | 55,776 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-01-31 | 2019-02-04 | 105,750 | — | $0 | 105,750 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-01-31 | 2019-02-04 | 278,400 | — | $0 | 278,400 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-08-02 | 2018-08-03 | 32,000 | — | $0 | 32,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-08-02 | 2018-08-03 | 7,500 | — | $0 | 7,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-07-25 | 2018-07-27 | 77,500 | — | $0 | 77,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2018-06-23 | 2018-06-26 | 10,000 | $3.82 | $38.2K | 22,740 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-01-31 | 2018-02-02 | 22,500 | — | $0 | 22,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-01-31 | 2018-02-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 42,210 | — | $0 | 42,210 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 46,580 | — | $0 | 46,580 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 113,000 | — | $0 | 113,000 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 55,900 | — | $0 | 55,900 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other | 2017-06-23 | 2017-06-27 | 12,740 | — | $0 | 12,740 | SEC↗ |
| NBRV Nabriva Therapeutics AG | A Award deriv | 2017-02-07 | 2017-02-09 | 11,300 | — | $0 | 11,300 | SEC↗ |